Abstract Polymorphonuclear leukocytes (PMNs) have been implicated in the pathogenesis of COPD, partly because of the release of oxidants, like superoxide anion (SA).The goal of this study was to measure the spontaneous and stimulated release of SA by peripheral PMN in stable COPD compared with healthy controls. Seventeen patients with stable moderate COPD and 17 healthy age-matched controls were included. SA release from peripheral PMN was measured spectrophotometrically as the superoxide dismutase (SOD) inhibitable reduction of cytochrome c. PMNs were stimulated with phorbol myristate acetate (PMA,1and10 ng/ml), diesel exhaust particles (DEPs), carbon black (CB) and ultrafine CB (ufCB,125, 250 and 500 mg/ml).The spontaneous SA release (PMA-0) between patients and control subjects was not significantly different. After stimulation with PMA, SA release increased in both patients and controls.The SA release did not increase after stimulation with DEP and CB in patients norin controls.There was only anincrease after stimulation with ufCB in the patient group.The increased SA release in COPD patients after stimulation with ufCB may suggestthat PMN of COPD patients are more prone to stimulation and thatthe smaller particle size of ufCB might be a crucial factor.
INTRODUCTION
Polymorphonuclear leukocytes (PMNs) have been implicated in the pathogenesis of COPD. They are involved in the in£ammatory process, re£ected by an increased number of neutrophils in sputum, bronchoalveolar lavage £uid (BAL £uid) and bronchial biopsies in smokers and COPD patients (1^5). In addition, a large pool of PMNs is present within the microvessels of the lung (6) .
Following a stimulus (e.g. infection, injury, inhalation of smoke and particulate matter), PMNs migrate from the peripheral blood into the extravascular space. Some migrate to the lungs and through the endothelium into the airway lumen, where they perform their 'task'of phagocytosis and destruction of an intruding organism or particle (7, 8) . Bosken et al. showed that the number of submucosal PMNs is related to the amount smoked (4) . A possible mechanism is that alveolar macrophages of smokers release a chemotactic factor for neutrophils (5) .
Eventually, the accumulation and activation of PMN may result in an adverse e¡ect of destruction of parenchymal tissue (i.e. development of emphysema), both through proteolysis by the elastase released from the lysosomal granules and the release of reactive oxygen-derived species (ROS), like superoxide anion (SA) and hydrogen peroxide (H 2 O 2 ). In vivo evidence for an increased oxidative burden has been provided by Dekhuijzen et al. who showed that patients with stable COPD had higher concentrations of H 2 O 2 in exhaled breath condensate than healthy control subjects (9) . The production of H 2 O 2 was further increased during exacerbations.
The increased oxidative burden is not only determined by an increase in the number of in£ammatory cells like PMN, but also by an increased production of oxidants per cell (10) . In healthy smokers, PMN showed increased production of oxidants (11) . In COPD patients, Teramoto et al. showed that spontaneous production of oxidants (SA) by PMN was similar to normal subjects. In contrast, Noguera et al. showed an increased production of oxidants by PMN in COPD patients compared with smokers with normal lung function (12, 13) . Two studies showed that the production of oxidants by PMN was increased after stimulation with phorbol myristate acetate (PMA) in COPD patients compared with healthy smokers (12, 13) . The production was also higher in smokers compared with non-smokers (11) .
Elevated concentrations of respirable particulate [i.e. ¢ne particles with a diameter less than10 mm in diameter (PM 10 )] have been implicated in adverse health e¡ects, including COPD (14, 15) . Respirable particulates contain a variety of toxic substances on their surface and arise amongst others from motor vehicle exhausts, especially those emitted from diesel engines (16) . These diesel exhaust particles (DEPs) contain both dust (elemental carbon), traces of heavy metals and organic components, which both enhance production of ROS by alveolar macrophages in vitro (17, 18) . In animal studies, intratracheal instillation of DEP, carbon black (CB) and ultra¢ne particulate (ufCB), caused an acute in£ammatory response with an in£ux of PMN in alveolar air spaces and interstitium (17^19). Respirable particulate can also be used to stimulate PMN directly.
The e¡ects of stimulation with respirable particulate on SA generation by PMN of COPD patients in vitro, are not known.Therefore, the aim of the present study was to compare the release of SA by peripheral PMN, both spontaneously and after stimulation with PMA, DEP, CB and ufCB between stable COPD patients and healthy controls.
METHODS Subjects
Seventeen patients diagnosed with (stable) COPD according to the criteria of the ERS (20) participated in this study. Inclusion criteria were: age o75 years, current or ex-smoker, forced expiratory volume in 1s (FEV 1 ) between o70 % of predicted or FEV 1 /FVC o60 % of predicted and reversibility less than15% of predicted after inhalation of 400 mg salbutamol or 80 mg ipratropium bromide. Further, 17 healthy age-matched control subjects were recruited. Exclusion criteria for both healthy controls and patients were a history of asthma, allergy, atopic constitution, known a 1 -proteinase inhibitor de¢ciency or other pulmonary diseases, an exacerbation or cold within the previous 8 weeks and use of supplemental dietary anti-oxidants, vitamins or N-acetylcystein. Both control subjects and patients were considered to be ex-smokers if they had discontinued smoking for at least 1 year prior to the study. This study was approved by the local Ethical Committee and informed consent was obtained from all subjects.
Sample collection and preparation
From each participant, 30 ml of venous lithium-heparinized blood was collected at 16.00 h. Samples were kept overnight at room temperature in the dark and prepared according to Schalkwijk et al. (21) at the next day at 08.00 h. After centrifugation, plasma was removed and the bu¡y coat diluted 1:1 with physiological saline. Subsequently, 8 ml of the plasma expander Plasmasteril was added for sedimentation of the red cells.
The dextran plasma layer, containing plasma, lymphocytes and monocytes was collected and 7 ml of FicollĤ ipaque solution (Pharmacia Biotech) with a density of 1.070 g/ml was gently brought under the supernatant. After centrifugation at room temperature during 20 min at 2000 rpm, the plasma, lymphocytes, monocytes and Ficoll^Hipaque were removed. The remaining PMNs (density 1.080 g/ml) and erythrocytes (density 1.085 g/ml) in the cell pellet were suspended in 0.5 ml Hanks' balanced salt solution (HBSS), and 13 ml of aqua pure was added to lysate the erythrocytes. After centrifugation at 41C during 5 min at 1000 rpm, the cell pellet was washed with HBSS and ¢nally resuspended in 2.5 ml HBSS + 0.1% glucose.
The total and di¡erential cell counts were performed with a standard hemocytometer. Viability was assessed with the trypane blue exclusion test. The yield of PMN was 30^40 % of the ¢rst sample with a high percentage of neutrophils [mean (SEM) 92.4 % (0.37)] and a viability of 98% or more.
Superoxide assay
SA release was measured spectrophotometrically as the superoxide dismutase (SOD) inhibitable reduction of cytochrome c, adapted for 96 -well assay. Brie£y, 25 ml of HBSS was added to 50 ml of cytochrome c (640 mM, Sigma Chemicals), 25 ml of SOD (2400 U/ml, Sigma Chemicals), 25 ml of PMN suspension (4 Â10 6 /ml) and 50 ml of stimulus. For measurement of spontaneous release no stimulus was added (PMA-0). For measurement of release, with (25 ml) and without SOD and with (50 ml) and without cells, respectively, the ¢nal volume of 200 ml was adjusted by adding HBSS.
Stimuli
PMA (Phorbol 12-Myristate 13-Acetate, Sigma Chemicals) was used as a stimulus in a concentration of 1 and 10 ng/ml. Samples were incubated during 30 min at 371C. The extinction was measured every 2 min at 540 and 550 nm using a Softmax 96 -wells microplate reader. Since there was a linear increase up to 30 min for both patients and healthy control subjects, the extinction after 30 min was used to calculate the concentration of reduced cytochrome with a extinction coe⁄cient of 14 964 L/mol cm.
DEP were collected from a 4 kW diesel engine (Yanmar, L90E, single cylinder). DEP, CB (acetylene carbon black, Strem, Newsburyport, MA, U.S.A.) and ufCB (Printex-90, diameter 20 nm, surface area 33.7 m 2 /g) were suspended in a ¢nal concentration of 2 mg/ml phosphate-bu¡ered saline with 0.05% Tween-80 after soni¢cation (MSE 100 Watt, Ultrasonic Disintegrator 7100). Concentrations of 125, 250 and 500 mg/ml were prepared. After stimulation, reaction mixtures were incubated at 371C during 30 min in a 24 -well plate.
Since addition of these stimuli caused a black mixture, measurement of extinction in time was not possible. Therefore, samples were ¢ltered after 30 min and extinction of the supernatant was measured in the 96 -well microplate reader. The addition of 500 mg/ml ufCB to PMN probably caused a toxic reaction, since cells coagulated and SA release was diminished. Therefore, the results of stimulation with 500 mg/ml ufCB were disregarded.
All samples were prepared in duplicate and the average value of the extinction was used for calculation. Finally, the SOD inhibitable reduction of cytochrome c was calculated as the di¡erences in extinction between the wells with and without SOD.
The results were expressed as the concentration of reduced cytochrome c (nmol/ml) per 1 Â 10 6 PMN per 30 min.
Statistical analysis
Data are expressed as mean and standard error of the mean (SEM). Di¡erences between patients with COPD and healthy controls were analysed with the Student's ttest for independent samples. In£uence of smoking and use of medication was analysed by analysis of covariance. The slope of SA release with increasing concentration of the stimuli was calculated with the linear regression equation. Di¡erences in the slope between groups were tested with the Mann-Whitney U-test using the individual slopes. Di¡erences in the slopes within groups between similar stimuli were tested with the Friedman's analysis of variance for related samples. For all analyses, a P-value less than 0.05 was considered signi¢cant.
RESULTS

Subjects
Seventeen COPD patients [mean FEV 1 56.6 (4.9)% of predicted] and 17 healthy controls were included (Table 1) .
Spontaneous SA release
The spontaneous SA release (PMA-0) between patients and control subjects was not signi¢cantly di¡erent [mean (SEM) 10.4(1.4) vs. 10.3(0.9)nmol/ml per 10 6 cells per 30 min, P = 0.9] (Fig. 1) . Both smoking history and use of medication did not in£uence this result (data not shown). The concentrations of DEP-0, CB-0 and ufCB-0 in the patient group were 5.5 (0.9), 4.7 (0.8), and 4.2 (0.9) nmol/ Mean (SEM), FEV 1 = forced expiratory volume in 1 second; reversibility = change in FEV 1 after 400 mg salbutamol; na = not applicable; ICS = inhaled corticosteroids.
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6 cells per 30 min, respectively. In the healthy control group, the concentrations were 6.1 (0.8), 6.3 (0.7), and 5.1 (0.7) nmol/ml 10 6 cells per 30 min, respectively. There were no signi¢cant di¡erences between patients and healthy controls.
SA release after stimulation with PMA
The concentration of reduced cytochrome c per10 6 cells per 30 min after stimulation with 1ng/ml PMA (PMA-1) and 10 ng/ml PMA (PMA-10), increased signi¢cantly in both patients and control subjects (Po0.01, Po0.01, respectively) (Fig. 1) . The mean concentration for PMA-1 was 24.84 (2.14) nmol/ml in patients and 27.9 (2.4) nmol/ ml in healthy controls (P = 0.34). For PMA-10, the mean concentration was 45.1 (10.7) nmol/ml in patients and 45.3 (10.5) nmol/ml in healthy controls (P = 0.95).
No signi¢cant di¡erences in SA release nor in the slope of increase in SA release were observed between patients and control subjects. Smoking and the use of ICS did not in£uence the results (data not shown).
SA release after stimulation with DEP,CB and ufCB
The mean concentrations of reduced cytochrome c per 10 6 cells per 30 min were similar in patients and healthy controls, and did not increase after stimulation with DEP (Fig. 2) . After stimulation with CB a small increase in SA release was observed in patients (Fig. 3) .Yet, the slope of increase in patients compared to controls was not significantly di¡erent. In contrast, after stimulation with ufCB, the slopes of increases were signi¢cantly di¡erent (P = 0.02) (Fig. 4) , i.e. an increased SA release in patients compared with healthy controls. Again, smoking history and the use of medication did not in£uence the results with respect to DEP, CB and ufCB (data not shown).
DISCUSSION
The present study shows that the spontaneous release of SA by peripheral PMN in COPD is not increased, compared with healthy control subjects. After stimulation with PMA, SA release was equally increased in both COPD patients and healthy controls. After stimulation with DEP and CB, the SA release was not increased in patients nor in healthy controls. Only after stimulation with ufCB the SA release was signi¢cantly higher in COPD patients.
The results of the present study are in accordance with the study of Teramoto et al., who also found no difference in spontaneous SA release between COPD patients and healthy controls (12) . In contrast with Ludwig et al., we observed no di¡erences between smoking and non-smoking individuals (11). Postma et al. did not ¢nd a di¡erence between smokers and ex-smokers with chronic air£ow obstruction either (22) .
In contrast to the present study, Noguera et al. found that the production of ROS by PMN was increased in patients with COPD compared with healthy smokers and non-smokers (13) . However, they measured the ROS production by the NADPH oxidase method and not by SA release, which makes it di⁄cult to compare results.
The use of ICS did not in£uence the results in the present study.Verhoeven et al. also found no e¡ect of inhaled £uticasone propionate on superoxide production by pulmonary cells retrieved with BAL in smoking COPD patients (23) .
The failure to demonstrate di¡erences in spontaneous SA release may suggest that the rest status of PMN in stable COPD patients is not di¡erent from that in controls. However, SA is only one of the oxidants that is produced by PMN, they also produce H 2 O 2 and hydroxyl radicals.
On the other hand, since formation of SA occurs prior to other members of ROS, di¡erences in production of other oxidants by PMN at rest between COPD patients and healthy controls is very unlikely.
The concentrations of DEP-0, CB-0 and ufCB-0 were lower than the PMA-0 concentration. Since addition of these stimuli caused a black mixture, measurement of extinction in time was not possible. Therefore, samples were analysed as described in the method section, which may explain the di¡erence in baseline value.
The data of the present study show that the release of SA by PMN after stimulation with PMA is equally increased in COPD patients and healthy controls. This is in contrast with the data presented by several other investigators (12, 13, 22) .
As mentioned above it is di⁄cult to compare our results with the results of Noguera et al. because of the difference in technique (13) . The di¡erence in result between our study and the study by Postma et al. could be due to the time of reaction (22) . They measured the SA release after 15 min of reaction while in the present study the SA release was measured after 30 min. Indeed, the SA release was higher in our study using the same PMA concentration. It is possible that the di¡erence in SA release between PMN of COPD patients and healthy controls present at15 min disappears after a longer reaction time. Teramoto et al. measured the SA release in whole blood by chemiluminescence, since in their opinion this is more likely to re£ect the in vivo situation (12) . Unfortunately, comparison with the current data is di⁄-cult, primarily due to the di¡erent methodologies applied.
After stimulation with particles present in environmental air (DEP, CB and ufCB), SA release increased only after ufCB stimulation in COPD patients.
To our knowledge, the e¡ect of stimulation with respirable particles on PMN of COPD patients has not been studied. It seems that exposure to DEP leads to accumulation of PMN, possibly through chemotactic agents, but not to increased production of oxidants by PMN (17, 19) . Only ufCB had an e¡ect on the production of oxidants by PMN in COPD patients in this study. This e¡ect may be explained by the smaller particle size of ufCB. Several studies have shown that ufCB is more in£ammogenic than other particulates, probably caused by increased surface area (24^27).The increased production after stimulation with ufCB was not observed in controls.Consequently, these data suggest a di¡erent response of PMN to ultra¢ne particles in vitro. PMN of COPD patients react stronger to stimulation with small respirable particles, which suggests that there is a di¡er-ence between PMN of COPD patients and PMN of healthy persons.
In conclusion, the increased SA release in COPD patients with increasing concentrations of ufCB may suggest that PMN in COPD patients are di¡erent from PMN in healthy persons. Furthermore, the smaller particle size of ufCB is a crucial factor in the stimulation of PMN, since similar observations were not made after stimulation with DEP and CB. 
